From: Elevated MED28 expression predicts poor outcome in women with breast cancer
MED28 Expression | Dichotomized | Continuous | ||||
---|---|---|---|---|---|---|
Low | High | P-Value | ± σ | P-Value | ||
All Invasive Patients | N = 88 | N = 66 | N = 22 | 0.946 ± 0.668 | ||
Age at Diagnosis | = 55.2 | = 55.9 | 0.8926a | ρ = 0.024b | 0.8195b | |
Median (Range) | 53 (30 - 89) | 53.5 (30 - 89) | 52 (36 - 89) | |||
25th to 75th Quartile | 45 - 66 | 45 - 74 | 45 - 77.2 | |||
Clinical Stage | = 1.712 | = 2.318 | 0.0035a | 0.0052b | ||
I | 33 | 28 | 5 | 0.0028d | 0.782 ± 0.721 | 0.0090e |
II | 36 | 30 | 6 | 0.918 ± 0.541 | ||
III | 17 | 7 | 10 | 1.312 ± 0.708 | ||
IV | 2 | 1 | 1 | 1.075 ± 0.813 | ||
Tumor Grade | = 2.063 | = 2.455 | 0.0678a | 0.0061b | ||
1 | 23 | 21 | 2 | 0.0882d | 0.598 ± 0.429 | 0.0099f |
2 | 25 | 17 | 8 | 1.009 ± 0.698 | ||
3 | 37 | 25 | 12 | 1.112 ± 0.726 | ||
Unknown | 3 | 3 | 0 | |||
Lymph Node Metastasis | 0.1004c | 0.0303a | ||||
Absent | 38 | 32 | 6 | 0.833 ± 0.775 | ||
Present | 34 | 22 | 12 | 1.083 ± 0.612 | ||
Unknown† | 16 | 12 | 4 | |||
Tumor Size (cm) | = 2.175 | = 2.955 | 0.0283a | ρ = 0.303b | 0.0060b | |
Median (Range) | 2.2 (0.1 - 9.0) | 2.0 (0.1 - 7.25) | 2.5 (0.5 - 9.0) | |||
25th to 75th Quartile | 1.18 - 3.00 | 1.0 - 2.5 | 1.7 - 4.0 | |||
Lymphovascular Invasion | 0.0720c | 0.0201a | ||||
Absent | 55 | 45 | 10 | 0.812 ± 0.599 | ||
Present | 32 | 20 | 12 | 1.177 ± 0.734 | ||
Unknown | 1 | 1 | 0 | |||
ER Status | 0.2514c | 0.0489a | ||||
Positive | 62 | 48 | 14 | 0.866 ± 0.594 | ||
Negative | 21 | 13 | 8 | 1.271 ± 0.822 | ||
Unknown | 5 | 5 | 0 | |||
PR Status | 0.0640c | 0.1828a | ||||
Positive | 58 | 47 | 11 | 0.864 ± 0.562 | ||
Negative | 28 | 17 | 11 | 1.142 ± 0.838 | ||
Unknown | 2 | 2 | 0 | |||
HER-2/neu Status | 0.0335c | 0.1022a | ||||
Positive | 19 | 10 | 9 | 1.181 ± 0.644 | ||
Negative | 61 | 49 | 12 | 0.923 ± 0.661 | ||
Unknown | 8 | 7 | 1 |